Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (22.04.2026)
HOCH Abgang Schlüsselpersonen (22.04.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 22.04.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo |
| 30.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo |
| 08.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo |
| 13.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointmen |
| 19.04.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp |
| 22.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | This Current Report on Form 8-K/A amends Item 5.02 of the Current Report on Form 8-K filed on November 14, 2022 (the “ |
| 22.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | This Current Report on Form 8-K/A amends Item 5.02 of the Current Report on Form 8-K filed on November 7, 2022 (the “R |
Stammdaten
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Unternehmen & Branche
| Name | DocGo Inc. |
|---|---|
| Ticker | DCGO |
| CIK | 0001822359 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Care Facilities |
| SIC | 8000 · Services-Health Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 69,4 Mio. USD |
| Beta | 0,98 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 322,196,000 | -182,399,628 | -1.84 | 217,103,012 | 144,011,839 |
| 2025-09-30 | 10-Q | 70,809,635 | -27,768,386 | -0.28 | 353,782,879 | 270,532,470 |
| 2025-06-30 | 10-Q | 80,417,622 | -11,155,246 | -0.11 | 408,263,751 | 297,277,710 |
| 2025-03-31 | 10-Q | 96,033,055 | -9,405,315 | -0.09 | 430,792,998 | 309,337,134 |
| 2024-12-31 | 10-K | 616,555,132 | 19,992,143 | 0.18 | 455,621,132 | 320,917,476 |
| 2024-09-30 | 10-Q | 138,684,814 | 5,497,901 | 0.05 | 493,882,539 | 325,213,345 |
| 2024-06-30 | 10-Q | 164,949,716 | 6,529,603 | 0.06 | 488,165,687 | 315,155,614 |
| 2024-03-31 | 10-Q | 192,087,529 | 11,227,449 | 0.10 | 490,685,117 | 311,324,082 |
| 2023-12-31 | 10-K | 624,288,642 | 6,858,455 | 0.06 | 490,451,957 | 300,794,867 |
| 2023-09-30 | 10-Q | 186,552,910 | 0.05 | 419,784,142 | 287,599,115 | |
| 2023-06-30 | 10-Q | 125,486,760 | -0.02 | 390,286,045 | 279,772,597 | |
| 2023-03-31 | 10-Q | 113,002,703 | -3,465,670 | -0.03 | 407,545,176 | 278,677,419 |
| 2022-12-31 | 10-K | 440,515,746 | 34,584,498 | 0.34 | 393,277,628 | 273,230,666 |
| 2022-09-30 | 10-Q | 104,319,894 | 2,466,486 | 0.03 | 355,920,210 | 264,219,841 |
| 2022-06-30 | 10-Q | 109,519,304 | 11,755,862 | 0.11 | 331,855,388 | 247,092,734 |
| 2022-03-31 | 10-Q | 117,891,552 | 10,629,694 | 0.09 | 325,196,304 | 231,983,556 |
| 2021-12-31 | 10-K | 318,718,580 | 23,743,758 | 0.25 | 309,602,652 | 219,582,014 |
| 2021-09-30 | 10-Q | 85,838,988 | 801,566 | 0.04 | 115,288,058 | -12,666,124 |
| 2021-06-30 | 10-Q | 62,185,997 | 102,007 | -18.19 | 115,464,516 | -13,210,611 |
| 2021-03-31 | 10-Q | 49,688,856 | -1,998,996 | -0.03 | 115,725,964 | -10,168,044 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | Tendler Ely D | Director, Officer, General Counsel and Secretary | Open Market Sale | -16,850 | 0.91 | -15,333.50 | -81,3% | |
| 2025-05-23 | Burdiek Michael J | Director | Open Market Purchase | 10,000 | 1.33 | 13,300.00 | +70,5% | |
| 2025-05-15 | Burdiek Michael J | Director | Open Market Purchase | 15,000 | 1.43 | 21,450.00 | +113,8% | |
| 2025-05-14 | Bienstock Lee | Director, Officer, Chief Executive Officer | Open Market Purchase | 15,000 | 1.54 | 23,100.00 | +122,5% | |
| 2025-05-14 | ROSENBERG NORMAN | Officer, CFO and Treasurer | Open Market Purchase | 15,000 | 1.47 | 22,050.00 | +116,9% | |
| 2025-05-14 | Klasko Stephen K. M.D. | Director | Open Market Purchase | 15,000 | 1.49 | 22,350.00 | +118,5% | |
| 2025-05-14 | Sugrue Stephen | Officer, Chief Compliance Officer | Open Market Purchase | 10,000 | 1.44 | 14,400.00 | +76,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.